417 related articles for article (PubMed ID: 25860510)
1. The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma.
Darda L; Hakami F; Morgan R; Murdoch C; Lambert DW; Hunter KD
PLoS One; 2015; 10(4):e0122285. PubMed ID: 25860510
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
[TBL] [Abstract][Full Text] [Related]
3. Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b.
Álvarez-Teijeiro S; Menéndez ST; Villaronga MÁ; Pena-Alonso E; Rodrigo JP; Morgan RO; Granda-Díaz R; Salom C; Fernandez MP; García-Pedrero JM
Sci Rep; 2017 Jul; 7(1):6790. PubMed ID: 28754915
[TBL] [Abstract][Full Text] [Related]
4. The effect and mechanism of miR196a in HepG2 cell.
Hao Y; Wang J; Zhao L
Biomed Pharmacother; 2015 May; 72():1-5. PubMed ID: 26054667
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.
Suh YE; Raulf N; Gäken J; Lawler K; Urbano TG; Bullenkamp J; Gobeil S; Huot J; Odell E; Tavassoli M
Int J Cancer; 2015 Sep; 137(5):1021-34. PubMed ID: 25523631
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
7. The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC).
Hakami F; Darda L; Stafford P; Woll P; Lambert DW; Hunter KD
Br J Cancer; 2014 Aug; 111(4):807-16. PubMed ID: 25010866
[TBL] [Abstract][Full Text] [Related]
8. miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue.
Kim YJ; Bae SW; Yu SS; Bae YC; Jung JS
J Bone Miner Res; 2009 May; 24(5):816-25. PubMed ID: 19063684
[TBL] [Abstract][Full Text] [Related]
9. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
Kinoshita T; Nohata N; Watanabe-Takano H; Yoshino H; Hidaka H; Fujimura L; Fuse M; Yamasaki T; Enokida H; Nakagawa M; Hanazawa T; Okamoto Y; Seki N
Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA HOTAIR/microRNA-206 sponge regulates STC2 and further influences cell biological functions in head and neck squamous cell carcinoma.
Li T; Qin Y; Zhen Z; Shen H; Cong T; Schiferle E; Xiao S
Cell Prolif; 2019 Sep; 52(5):e12651. PubMed ID: 31297902
[TBL] [Abstract][Full Text] [Related]
11. miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
Huang Q; Shen YJ; Hsueh CY; Guo Y; Zhang YF; Li JY; Zhou L
BMC Cancer; 2021 Oct; 21(1):1074. PubMed ID: 34598688
[TBL] [Abstract][Full Text] [Related]
12. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.
Kinoshita T; Hanazawa T; Nohata N; Kikkawa N; Enokida H; Yoshino H; Yamasaki T; Hidaka H; Nakagawa M; Okamoto Y; Seki N
Oncotarget; 2012 Nov; 3(11):1386-400. PubMed ID: 23159910
[TBL] [Abstract][Full Text] [Related]
14. MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
Liu F; Zhao X; Qian Y; Zhang J; Zhang Y; Yin R
Biomed Pharmacother; 2017 Dec; 96():229-237. PubMed ID: 28987947
[TBL] [Abstract][Full Text] [Related]
15. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines.
Sun Z; Li S; Kaufmann AM; Albers AE
Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929
[TBL] [Abstract][Full Text] [Related]
16. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
[TBL] [Abstract][Full Text] [Related]
17. MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC).
Zhang J; Wang Y; Chen X; Zhou Y; Jiang F; Chen J; Wang L; Zhang WF
Oncotarget; 2015 Apr; 6(10):7454-69. PubMed ID: 25762634
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
Kinoshita T; Nohata N; Fuse M; Hanazawa T; Kikkawa N; Fujimura L; Watanabe-Takano H; Yamada Y; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
Biochem Biophys Res Commun; 2012 Feb; 418(2):378-83. PubMed ID: 22266319
[TBL] [Abstract][Full Text] [Related]
19. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
20. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.
Nohata N; Hanazawa T; Kinoshita T; Inamine A; Kikkawa N; Itesako T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
Br J Cancer; 2013 Apr; 108(8):1648-58. PubMed ID: 23558898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
